Thailand has been a leader in HIV/AIDS research and treatment, and the country provides free or low-cost medical care for people living with HIV. The Thai government has also been a leader in developing anti-retroviral therapies (ART), and as a result, Thailand has one of the lowest rates of HIV/AIDS-related deaths in the world.
There are two types of ART available in Thailand: first-line therapy and second-line therapy. First-line therapy is a combination of three drugs typically used to treat people who have just been diagnosed with HIV. Second-line therapy is a combination of four drugs typically used to treat people who have developed resistance to first-line therapies.
There are also several different second-line therapies available in Thailand, and treatment choice again depends on the patient's unique medical history and drug resistance profile. The most common second-line therapies in Thailand are: Prezista (darunavir), Intelence (etravirine), and Viracept (nelfinavir).